Catherine Eckford2024-08-28T19:31:25
The multi-target biologic-focused agreement could enhance treatment convenience by improving subcutaneous administration options for patients.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-07-13T07:00:00
Sponsored by Thermo Fisher Scientific
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-11-05T15:00:00
Sponsored by FUJIFILM Wako Chemicals Europe GmbH
2026-05-27T13:00:00
Sponsored by TA Instruments
Site powered by Webvision Cloud